Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 22 entries
Sorted by: Best Match Show Resources per page
Models of Care in Geriatric Oncology.

Current geriatrics reports

Magnuson A, Dale W, Mohile S.
PMID: 25587518
Curr Geriatr Rep. 2014 Sep;3(3):182-189. doi: 10.1007/s13670-014-0095-4.

Cancer is common in older adults and the approach to cancer treatment and supportive measures in this age group is continuously evolving. Incorporating geriatric assessment (GA) into the care of the older patient with cancer has been shown to...

Cite
Magnuson A, Dale W, Mohile S. Models of Care in Geriatric Oncology. Curr Geriatr Rep. 2014;3(3):182-189doi: 10.1007/s13670-014-0095-4.
Magnuson, A., Dale, W., & Mohile, S. (2014). Models of Care in Geriatric Oncology. Current geriatrics reports, 3(3), 182-189. https://doi.org/10.1007/s13670-014-0095-4
Magnuson, A, et al. "Models of Care in Geriatric Oncology." Current geriatrics reports vol. 3,3 (2014): 182-189. doi: https://doi.org/10.1007/s13670-014-0095-4
Magnuson A, Dale W, Mohile S. Models of Care in Geriatric Oncology. Curr Geriatr Rep. 2014 Sep;3(3):182-189. doi: 10.1007/s13670-014-0095-4. PMID: 25587518; PMCID: PMC4289627.
Copy Download .nbib Format: NLM
Self-reported cognitive impairment in patients with cancer.

Journal of oncology practice

Kohli S, Griggs JJ, Roscoe JA, Jean-Pierre P, Bole C, Mustian KM, Hill R, Smith K, Gross H, Morrow GR.
PMID: 20859374
J Oncol Pract. 2007 Mar;3(2):54-9. doi: 10.1200/JOP.0722001.

PURPOSE: Cancer patients often report cognitive impairment, manifested as problems with concentration and memory, following cancer therapy. As part of a large multicenter survey of cancer patients undergoing treatment, we investigated the frequency and severity of self-reported problems with...

Cite
Kohli S, Griggs JJ, Roscoe JA, et al. Self-reported cognitive impairment in patients with cancer. J Oncol Pract. 2007;3(2):54-9doi: 10.1200/JOP.0722001.
Kohli, S., Griggs, J. J., Roscoe, J. A., Jean-Pierre, P., Bole, C., Mustian, K. M., Hill, R., Smith, K., Gross, H., & Morrow, G. R. (2007). Self-reported cognitive impairment in patients with cancer. Journal of oncology practice, 3(2), 54-9. https://doi.org/10.1200/JOP.0722001
Kohli, Sadhna, et al. "Self-reported cognitive impairment in patients with cancer." Journal of oncology practice vol. 3,2 (2007): 54-9. doi: https://doi.org/10.1200/JOP.0722001
Kohli S, Griggs JJ, Roscoe JA, Jean-Pierre P, Bole C, Mustian KM, Hill R, Smith K, Gross H, Morrow GR. Self-reported cognitive impairment in patients with cancer. J Oncol Pract. 2007 Mar;3(2):54-9. doi: 10.1200/JOP.0722001. PMID: 20859374; PMCID: PMC2793748.
Copy Download .nbib Format: NLM
Exercise and Cancer Treatment Symptoms in 408 Newly Diagnosed Older Cancer Patients.

Journal of geriatric oncology

Sprod LK, Mohile SG, Demark-Wahnefried W, Janelsins MC, Peppone LJ, Morrow GR, Lord R, Gross H, Mustian KM.
PMID: 22712028
J Geriatr Oncol. 2012 Apr 01;3(2):90-97. doi: 10.1016/j.jgo.2012.01.002. Epub 2012 Jan 27.

While the benefits of exercise for managing cancer-and treatment-related side effects has been shown among various populations of cancer survivors, a relative dearth of information exists among older cancer patients. OBJECTIVES: To determine the prevalence of exercise participation during...

Cite
Sprod LK, Mohile SG, Demark-Wahnefried W, et al. Exercise and Cancer Treatment Symptoms in 408 Newly Diagnosed Older Cancer Patients. J Geriatr Oncol. 2012;3(2):90-97doi: 10.1016/j.jgo.2012.01.002.
Sprod, L. K., Mohile, S. G., Demark-Wahnefried, W., Janelsins, M. C., Peppone, L. J., Morrow, G. R., Lord, R., Gross, H., & Mustian, K. M. (2012). Exercise and Cancer Treatment Symptoms in 408 Newly Diagnosed Older Cancer Patients. Journal of geriatric oncology, 3(2), 90-97. https://doi.org/10.1016/j.jgo.2012.01.002
Sprod, Lisa K, et al. "Exercise and Cancer Treatment Symptoms in 408 Newly Diagnosed Older Cancer Patients." Journal of geriatric oncology vol. 3,2 (2012): 90-97. doi: https://doi.org/10.1016/j.jgo.2012.01.002
Sprod LK, Mohile SG, Demark-Wahnefried W, Janelsins MC, Peppone LJ, Morrow GR, Lord R, Gross H, Mustian KM. Exercise and Cancer Treatment Symptoms in 408 Newly Diagnosed Older Cancer Patients. J Geriatr Oncol. 2012 Apr 01;3(2):90-97. doi: 10.1016/j.jgo.2012.01.002. Epub 2012 Jan 27. PMID: 22712028; PMCID: PMC3376161.
Copy Download .nbib Format: NLM
Palonosetron versus older 5-HT3 receptor antagonists for nausea prevention in patients receiving chemotherapy: a multistudy analysis.

The Journal of community and supportive oncology

Morrow GR, Schwartzberg L, Barbour SY, Ballinari G, Thorn MD, Cox D.
PMID: 25830233
J Community Support Oncol. 2014 Jul;12(7):250-8. doi: 10.12788/jcso.0058.

BACKGROUND: No clinical standard currently exists for the optimal management of nausea induced by emetogenic chemotherapy, 7particularly delayed nausea.OBJECTIVES: To compare the effcacy and safety of palonosetron with older 5-HT3 receptor antagonists (RAs) in preventing chemotherapy-induced nausea.METHODS: Data were...

Cite
Morrow GR, Schwartzberg L, Barbour SY, et al. Palonosetron versus older 5-HT3 receptor antagonists for nausea prevention in patients receiving chemotherapy: a multistudy analysis. J Community Support Oncol. 2014;12(7):250-8doi: 10.12788/jcso.0058.
Morrow, G. R., Schwartzberg, L., Barbour, S. Y., Ballinari, G., Thorn, M. D., & Cox, D. (2014). Palonosetron versus older 5-HT3 receptor antagonists for nausea prevention in patients receiving chemotherapy: a multistudy analysis. The Journal of community and supportive oncology, 12(7), 250-8. https://doi.org/10.12788/jcso.0058
Morrow, Gary R, et al. "Palonosetron versus older 5-HT3 receptor antagonists for nausea prevention in patients receiving chemotherapy: a multistudy analysis." The Journal of community and supportive oncology vol. 12,7 (2014): 250-8. doi: https://doi.org/10.12788/jcso.0058
Morrow GR, Schwartzberg L, Barbour SY, Ballinari G, Thorn MD, Cox D. Palonosetron versus older 5-HT3 receptor antagonists for nausea prevention in patients receiving chemotherapy: a multistudy analysis. J Community Support Oncol. 2014 Jul;12(7):250-8. doi: 10.12788/jcso.0058. PMID: 25830233; PMCID: PMC4734136.
Copy Download .nbib Format: NLM
Longitudinal Trajectory and Characterization of Cancer-Related Cognitive Impairment in a Nationwide Cohort Study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Janelsins MC, Heckler CE, Peppone LJ, Ahles TA, Mohile SG, Mustian KM, Palesh O, O'Mara AM, Minasian LM, Williams AM, Magnuson A, Geer J, Dakhil SR, Hopkins JO, Morrow GR.
PMID: 30240328
J Clin Oncol. 2018 Sep 21;JCO2018786624. doi: 10.1200/JCO.2018.78.6624. Epub 2018 Sep 21.

PURPOSE: Cancer-related cognitive impairment (CRCI) is an important clinical problem in patients with breast cancer receiving chemotherapy. Nationwide longitudinal studies are needed to understand the trajectory and severity of CRCI in specific cognitive domains.PATIENTS AND METHODS: The overall objective...

Cite
Janelsins MC, Heckler CE, Peppone LJ, et al. Longitudinal Trajectory and Characterization of Cancer-Related Cognitive Impairment in a Nationwide Cohort Study. J Clin Oncol. 2018;JCO2018786624doi: 10.1200/JCO.2018.78.6624.
Janelsins, M. C., Heckler, C. E., Peppone, L. J., Ahles, T. A., Mohile, S. G., Mustian, K. M., Palesh, O., O'Mara, A. M., Minasian, L. M., Williams, A. M., Magnuson, A., Geer, J., Dakhil, S. R., Hopkins, J. O., & Morrow, G. R. (2018). Longitudinal Trajectory and Characterization of Cancer-Related Cognitive Impairment in a Nationwide Cohort Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, JCO2018786624. https://doi.org/10.1200/JCO.2018.78.6624
Janelsins, Michelle C, et al. "Longitudinal Trajectory and Characterization of Cancer-Related Cognitive Impairment in a Nationwide Cohort Study." Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. (2018): JCO2018786624. doi: https://doi.org/10.1200/JCO.2018.78.6624
Janelsins MC, Heckler CE, Peppone LJ, Ahles TA, Mohile SG, Mustian KM, Palesh O, O'Mara AM, Minasian LM, Williams AM, Magnuson A, Geer J, Dakhil SR, Hopkins JO, Morrow GR. Longitudinal Trajectory and Characterization of Cancer-Related Cognitive Impairment in a Nationwide Cohort Study. J Clin Oncol. 2018 Sep 21;JCO2018786624. doi: 10.1200/JCO.2018.78.6624. Epub 2018 Sep 21. PMID: 30240328; PMCID: PMC6225503.
Copy Download .nbib Format: NLM
Treatment of Chemotherapy-Induced Nausea in Cancer Patients.

European oncology

Ryan JL.
PMID: 21984886
Eur Oncol. 2010;6(2):14-16. doi: 10.17925/eoh.2010.06.02.14.

For over 30 years, chemotherapy-induced nausea and vomiting have been the most severe and troublesome symptoms for cancer patients receiving chemotherapy. Unresolved chemotherapy-induced nausea and vomiting can lead to metabolic disorders, dehydration, nutritional depletion and esophageal tears, and can...

Cite
Ryan JL. Treatment of Chemotherapy-Induced Nausea in Cancer Patients. Eur Oncol. 2010;6(2):14-16doi: 10.17925/eoh.2010.06.02.14.
Ryan, J. L. (2010). Treatment of Chemotherapy-Induced Nausea in Cancer Patients. European oncology, 6(2), 14-16. https://doi.org/10.17925/eoh.2010.06.02.14
Ryan, Julie L. "Treatment of Chemotherapy-Induced Nausea in Cancer Patients." European oncology vol. 6,2 (2010): 14-16. doi: https://doi.org/10.17925/eoh.2010.06.02.14
Ryan JL. Treatment of Chemotherapy-Induced Nausea in Cancer Patients. Eur Oncol. 2010;6(2):14-16. doi: 10.17925/eoh.2010.06.02.14. PMID: 21984886; PMCID: PMC3188425.
Copy Download .nbib Format: NLM
Exercise and Cancer-related Fatigue.

US oncology

Mustian KM, Peppone LJ, Palesh OG, Janelsins MC, Mohile SG, Purnell JQ, Darling TV.
PMID: 21853012
US Oncol. 2009;5(2):20-23.

Cancer-related fatigue is the most common side effect reported by cancer patients during and after treatment. Cancer-related fatigue significantly interferes with a patient's ability to perform activities of daily living and maintain functional independence and quality of life. Cancer-related...

Cite
Mustian KM, Peppone LJ, Palesh OG, et al. Exercise and Cancer-related Fatigue. US Oncol. 2009;5(2):20-23
Mustian, K. M., Peppone, L. J., Palesh, O. G., Janelsins, M. C., Mohile, S. G., Purnell, J. Q., & Darling, T. V. (2009). Exercise and Cancer-related Fatigue. US oncology, 5(2), 20-23.
Mustian, Karen M, et al. "Exercise and Cancer-related Fatigue." US oncology vol. 5,2 (2009): 20-23.
Mustian KM, Peppone LJ, Palesh OG, Janelsins MC, Mohile SG, Purnell JQ, Darling TV. Exercise and Cancer-related Fatigue. US Oncol. 2009;5(2):20-23. PMID: 21853012; PMCID: PMC3156559.
Copy Download .nbib Format: NLM
Ginger.

Oncology nurse edition

Ryan JL, Morrow GR.
PMID: 27595143
Oncol Nurse Ed. 2010 Feb;24(2):46-49. Epub 2010 Feb 16.

No abstract available.

Cite
Ryan JL, Morrow GR. Ginger. Oncol Nurse Ed. 2010;24(2):46-49
Ryan, J. L., & Morrow, G. R. (2010). Ginger. Oncology nurse edition, 24(2), 46-49.
Ryan, Julie L, and Morrow, Gary R. "Ginger." Oncology nurse edition vol. 24,2 (2010): 46-49.
Ryan JL, Morrow GR. Ginger. Oncol Nurse Ed. 2010 Feb;24(2):46-49. Epub 2010 Feb 16. PMID: 27595143; PMCID: PMC5008850.
Copy Download .nbib Format: NLM
Considerations for Training Cancer Survivors.

Strength and conditioning journal

Sprod LK.
PMID: 21072134
Strength Cond J. 2009 Feb;31(1):39-47. doi: 10.1519/SSC.0b013e318195a259.

The incidence of cancer development has reached a plateau while cancer survival rates have been increasing. Therefore, more cancer survivors are living with the negative effects of cancer and cancer treatments. Exercise can play a significant role in combating...

Cite
Sprod LK. Considerations for Training Cancer Survivors. Strength Cond J. 2009;31(1):39-47doi: 10.1519/SSC.0b013e318195a259.
Sprod, L. K. (2009). Considerations for Training Cancer Survivors. Strength and conditioning journal, 31(1), 39-47. https://doi.org/10.1519/SSC.0b013e318195a259
Sprod, Lisa K. "Considerations for Training Cancer Survivors." Strength and conditioning journal vol. 31,1 (2009): 39-47. doi: https://doi.org/10.1519/SSC.0b013e318195a259
Sprod LK. Considerations for Training Cancer Survivors. Strength Cond J. 2009 Feb;31(1):39-47. doi: 10.1519/SSC.0b013e318195a259. PMID: 21072134; PMCID: PMC2975359.
Copy Download .nbib Format: NLM
Commentary: Family assessment in pediatric psychology.

Journal of pediatric psychology

Holmbeck GN, Devine KA.
PMID: 21325268
J Pediatr Psychol. 2011 Jun;36(5):642-6. doi: 10.1093/jpepsy/jsr004. Epub 2011 Feb 15.

No abstract available.

Cite
Holmbeck GN, Devine KA. Commentary: Family assessment in pediatric psychology. J Pediatr Psychol. 2011;36(5):642-6doi: 10.1093/jpepsy/jsr004.
Holmbeck, G. N., & Devine, K. A. (2011). Commentary: Family assessment in pediatric psychology. Journal of pediatric psychology, 36(5), 642-6. https://doi.org/10.1093/jpepsy/jsr004
Holmbeck, Grayson N, and Devine, Katie A. "Commentary: Family assessment in pediatric psychology." Journal of pediatric psychology vol. 36,5 (2011): 642-6. doi: https://doi.org/10.1093/jpepsy/jsr004
Holmbeck GN, Devine KA. Commentary: Family assessment in pediatric psychology. J Pediatr Psychol. 2011 Jun;36(5):642-6. doi: 10.1093/jpepsy/jsr004. Epub 2011 Feb 15. PMID: 21325268; PMCID: PMC3131708.
Copy Download .nbib Format: NLM
Exercise for Toxicity Management in Cancer-A Narrative Review.

Oncology & hematology review

Kleckner IR, Dunne RF, Asare M, Cole C, Fleming F, Fung C, Lin PJ, Mustian KM.
PMID: 29713475
Oncol Hematol Rev. 2018;14(1):28-37. Epub 2018 Feb 15.

Although the treatment of cancer is more effective now than ever, patients with cancer still face acute and chronic toxicities such as fatigue, cardiotoxicity, pain, cognitive impairment, and neurotoxicity. In this narrative review, we briefly discuss the use of...

Cite
Kleckner IR, Dunne RF, Asare M, et al. Exercise for Toxicity Management in Cancer-A Narrative Review. Oncol Hematol Rev. 2018;14(1):28-37
Kleckner, I. R., Dunne, R. F., Asare, M., Cole, C., Fleming, F., Fung, C., Lin, P. J., & Mustian, K. M. (2018). Exercise for Toxicity Management in Cancer-A Narrative Review. Oncology & hematology review, 14(1), 28-37.
Kleckner, Ian R, et al. "Exercise for Toxicity Management in Cancer-A Narrative Review." Oncology & hematology review vol. 14,1 (2018): 28-37.
Kleckner IR, Dunne RF, Asare M, Cole C, Fleming F, Fung C, Lin PJ, Mustian KM. Exercise for Toxicity Management in Cancer-A Narrative Review. Oncol Hematol Rev. 2018;14(1):28-37. Epub 2018 Feb 15. PMID: 29713475; PMCID: PMC5922767.
Copy Download .nbib Format: NLM
Exercise Recommendations for Cancer-Related Fatigue, Cognitive Impairment, Sleep problems, Depression, Pain, Anxiety, and Physical Dysfunction: A Review.

Oncology & hematology review

Mustian KM, Sprod LK, Janelsins M, Peppone LJ, Mohile S.
PMID: 23667857
Oncol Hematol Rev. 2012;8(2):81-88. doi: 10.17925/ohr.2012.08.2.81.

Cancer and its treatments produce a myriad of burdensome side effects and significantly impair quality of life (QOL). Exercise reduces side effects and improves QOL for cancer patients during treatment and recovery. Exercise prior to, during, and after completion...

Cite
Mustian KM, Sprod LK, Janelsins M, et al. Exercise Recommendations for Cancer-Related Fatigue, Cognitive Impairment, Sleep problems, Depression, Pain, Anxiety, and Physical Dysfunction: A Review. Oncol Hematol Rev. 2012;8(2):81-88doi: 10.17925/ohr.2012.08.2.81.
Mustian, K. M., Sprod, L. K., Janelsins, M., Peppone, L. J., & Mohile, S. (2012). Exercise Recommendations for Cancer-Related Fatigue, Cognitive Impairment, Sleep problems, Depression, Pain, Anxiety, and Physical Dysfunction: A Review. Oncology & hematology review, 8(2), 81-88. https://doi.org/10.17925/ohr.2012.08.2.81
Mustian, Karen M, et al. "Exercise Recommendations for Cancer-Related Fatigue, Cognitive Impairment, Sleep problems, Depression, Pain, Anxiety, and Physical Dysfunction: A Review." Oncology & hematology review vol. 8,2 (2012): 81-88. doi: https://doi.org/10.17925/ohr.2012.08.2.81
Mustian KM, Sprod LK, Janelsins M, Peppone LJ, Mohile S. Exercise Recommendations for Cancer-Related Fatigue, Cognitive Impairment, Sleep problems, Depression, Pain, Anxiety, and Physical Dysfunction: A Review. Oncol Hematol Rev. 2012;8(2):81-88. doi: 10.17925/ohr.2012.08.2.81. PMID: 23667857; PMCID: PMC3647480.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 22 entries